» Articles » PMID: 31577952

PINK1/Parkin Influences Cell Cycle by Sequestering TBK1 at Damaged Mitochondria, Inhibiting Mitosis

Abstract

PINK1 and Parkin are established mediators of mitophagy, the selective removal of damaged mitochondria by autophagy. PINK1 and Parkin have been proposed to act as tumor suppressors, as loss-of-function mutations are correlated with enhanced tumorigenesis. However, it is unclear how PINK1 and Parkin act in coordination during mitophagy to influence the cell cycle. Here we show that PINK1 and Parkin genetically interact with proteins involved in cell cycle regulation, and loss of PINK1 and Parkin accelerates cell growth. PINK1- and Parkin-mediated activation of TBK1 at the mitochondria during mitophagy leads to a block in mitosis due to the sequestration of TBK1 from its physiological role at centrosomes during mitosis. Our study supports a diverse role for the far-reaching, regulatory effects of mitochondrial quality control in cellular homeostasis and demonstrates that the PINK1/Parkin pathway genetically interacts with the cell cycle, providing a framework for understanding the molecular basis linking PINK1 and Parkin to mitosis.

Citing Articles

Role of Mitochondrial Dynamics in Skin Homeostasis: An Update.

Quan T, Li R, Gao T Int J Mol Sci. 2025; 26(5).

PMID: 40076431 PMC: 11898645. DOI: 10.3390/ijms26051803.


Adaptor-Mediated Trafficking of Tank Binding Kinase 1 During Diverse Cellular Processes.

Paul S, Biswas S, Milner J, Tomsick P, Pickrell A Traffic. 2025; 26(1-3):e70000.

PMID: 40047067 PMC: 11883510. DOI: 10.1111/tra.70000.


Salidroside enhances 5-fluorouracil sensitivity against hepatocellular carcinoma via YIPF5-induced mitophagy.

Sun S, Hu H, Li F, Huan S, Chen L, Chen J Front Pharmacol. 2025; 15():1503490.

PMID: 39834805 PMC: 11743563. DOI: 10.3389/fphar.2024.1503490.


Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species.

Ju S, Singh M, Han S, Ranbhise J, Ha J, Choe W Int J Mol Sci. 2024; 25(22).

PMID: 39596452 PMC: 11595237. DOI: 10.3390/ijms252212387.


In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery.

Ivanov J, Tenchov R, Ralhan K, Iyer K, Agarwal S, Zhou Q J Chem Inf Model. 2024; 64(19):7488-7502.

PMID: 39289178 PMC: 11480986. DOI: 10.1021/acs.jcim.4c00864.


References
1.
Onorati M, Li Z, Liu F, Sousa A, Nakagawa N, Li M . Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia. Cell Rep. 2016; 16(10):2576-2592. PMC: 5135012. DOI: 10.1016/j.celrep.2016.08.038. View

2.
Bennardo N, Cheng A, Huang N, Stark J . Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008; 4(6):e1000110. PMC: 2430616. DOI: 10.1371/journal.pgen.1000110. View

3.
Requejo-Aguilar R, Lopez-Fabuel I, Fernandez E, Martins L, Almeida A, Bolanos J . PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1. Nat Commun. 2014; 5:4514. DOI: 10.1038/ncomms5514. View

4.
Mao Z, Bozzella M, Seluanov A, Gorbunova V . Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst). 2008; 7(10):1765-71. PMC: 2695993. DOI: 10.1016/j.dnarep.2008.06.018. View

5.
Clement J, Meloche S, Servant M . The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 2009; 18(9):889-99. DOI: 10.1038/cr.2008.273. View